logo

Iridex Corp (IRIX)



Trade IRIX now with
  Date
  Headline
3/8/2017 4:14:15 PM IRIDEX Q4 Loss/share $1.04 Vs. Profit $0.04 Year Ago
1/9/2017 6:18:00 AM IRIDEX Reports Preliminary Revenues Of $12.4 Mln-$12.5 Mln And $46.0 Mln-$46.1 Mln For Q4 And 2016, Respectively
12/9/2016 8:47:42 AM IRIDEX Prices Public Offering Of An Aggregate Of 1.15 Mln Shares At $14/Shr
7/11/2016 6:37:19 AM IRIDEX: Atabak Mokari To Join As CFO And VP Of Corporate Development Effective July 11
2/16/2016 6:32:00 AM Iridex Gets CE Mark For Cyclo G6 Laser System For Treatment Of Multiple Stages Of Glaucoma
1/11/2016 6:37:42 AM IRIDEX Expects Q4 Revenues Of $11.9 Mln To $12.2 Mln Vs Prior Outlook Of $11.5 Mln - $11.9 Mln
8/6/2015 5:54:01 PM IRIDEX Q2 Loss/share $0.07 Vs. Profit $0.03 Year Ago
8/4/2015 5:35:52 PM IRIDEX CFO James Mackaness Resigns
7/16/2015 6:33:51 AM IRIDEX Reports Q2 Preliminary Revenues Of $9.0 Mln-$9.1 Mln,
5/7/2015 5:17:51 PM IRIDEX Posts Q1 Loss Per Share Of EPS Of $0.02 Vs. $0.05 Year Ago
3/30/2015 7:42:21 AM IRIDEX Granted U.S. Patent For Disposable Device For Efficient And Predictable Wound Closure In Eye Surgeries
3/17/2015 6:32:07 AM IRIDEX Announces First Commercial Sales Of New Cyclo G6™ Glaucoma Laser Systems
3/5/2015 4:35:38 PM IRIDEX Posts Q4 EPS Of $0.86 Vs. $0.04 Year Ago
2/2/2015 6:31:20 AM IRIDEX Gets FDA Clearance For Cyclo G6 Laser System For Treatment Of Multiple Stages Of Glaucoma
1/12/2015 6:44:18 AM IRIDEX Reports Q4 Preliminary Revenues Of About $11.5 Mln - $11.7 Mln
12/31/2014 4:18:04 PM IRIDEX Appoints George Marcellino To Board Of Directors
11/19/2014 6:33:38 AM IRIDEX Bags Large Tender From Government Of Zambia For Ophthalmology Laser Equipment
10/30/2014 5:58:01 PM IRIDEX Posts Q3 EPS Of $0.05 Vs. $0.05 Year Ago